Procan Technologies
- Diagnostics
- Other R&D services
- CMO, CRO
ProCan® Technologies, a global leader in cancer proteomics.
ProCan Technologies is a non-profit organisation leveraging proteomic insights to enhance the outcomes of oncology research and clinical trials globally. We de-risk and accelerate your oncology clinical trials by identifying the most appropriate patient population for your therapeutic .
Having developed world leading high throughput mass spectrometry methodologies, ProCan has analysed over 30,000 tumor samples in collaboration with more than 100 groups across the globe. The data comprises the world’s largest proteomic oncology database generated from a single platform. ProCan Technologies now offers the TargetQuantTM ADC panel, a mullti-plexed, targeted panel to directly quantify ADC target expression enabling improved patient selection into ADC clinical trials and personalised precision oncology.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}